Dec 14 (Reuters) - Gold eased on Monday as the roll out of
coronavirus vaccines in the United States lifted risk sentiment,
offsetting support from hopes for more U.S. economic stimulus
and a weaker dollar.
FUNDAMENTALS
* Spot gold XAU= fell 0.2% to $1,834.94 per ounce by 0053
GMT, while U.S. gold futures GCv1 eased 0.2% to $1,840.70.
* The first shipments of COVID-19 vaccine began on Sunday,
after a U.S. regulator approved Pfizer Inc PFE.N and BioNTech
SE BNTX.O 's vaccine.
* The text of a $908 billion bipartisan COVID-19 relief plan
is set to be released as early as Monday and will be split into
two packages in a bid to win approval, a person briefed on the
matter said. * The U.S. dollar shed 0.2% ahead of the U.S. Federal
Reserve's two-day meeting starting on Tuesday, where
policymakers are expected to increase purchases of longer-dated
Treasuries to contain a rise in yields. USD/
* Gold is seen as a hedge against inflation and currency
debasement.
* London and Brussels agreed on Sunday to "go the extra mile"
in coming days to try to reach a trade agreement, even as
British Prime Minister Boris Johnson said both parties were very
far apart on key issues and no deal Brexit was a possibility.
* Holdings in SPDR's Gold Trust GLD , the world's largest
gold-backed exchange-traded fund, fell 0.32% to 1,175.99 tonnes
on Friday from 1,179.78 tonnes on Thursday. * Hedge funds and money managers raised their bullish
positions in COMEX gold and silver contracts in the week to Dec.
8, the U.S. Commodity Futures Trading Commission (CFTC) said on
Friday. * Silver XAG= was little changed at $23.90 an ounce, while
platinum XPT= gained 0.6% to $1,015.03 and palladium XPD=
rose 0.4% to $2,327.57.
DATA AHEAD(GMT)
0630 India Nov. WPI Inflation
1000 EU Oct. Industrial Production